Selecta Biosciences (SELB) Tops Q1 EPS by 34c

Selecta Biosciences (NASDAQ: SELB) reported Q1 EPS of $0.23, $0.34 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $34 million versus the consensus estimate of $13.12 million.

For earnings history and earnings-related data on Selecta Biosciences (SELB) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Investing.com’s stocks of the week
• UBS Reiterates Buy Rating on Darden Restaurants (DRI) Ahead of Q1 Earnings